Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 7
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial.
Miyata Y, Araki K, Ohba K, Mastuo T, Nakamura Y, Yuno T, Mukai Y, Otsubo A, Mitsunari K, Mochizuki Y, Sakai H. Miyata Y, et al. Among authors: yuno t. Mol Clin Oncol. 2020 Oct;13(4):29. doi: 10.3892/mco.2020.2099. Epub 2020 Jul 20. Mol Clin Oncol. 2020. PMID: 32765876 Free PMC article.
Erratum: Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial.
Miyata Y, Araki K, Ohba K, Mastuo T, Nakamura Y, Yuno T, Mukai Y, Otsubo A, Mitsunari K, Mochizuki Y, Sakai H. Miyata Y, et al. Among authors: yuno t. Mol Clin Oncol. 2020 Dec;13(6):78. doi: 10.3892/mco.2020.2148. Epub 2020 Sep 25. Mol Clin Oncol. 2020. PMID: 33062268 Free PMC article.